Novel group of tyrosyl-DNA-phosphodiesterase 1 inhibitors based on disaccharide nucleosides as drug prototypes for anti-cancer therapy

• Autori principali: Anastasia O. Komarova (Autore), Mikhail S. Drenichev (Autore), Nadezhda S. Dyrkheeva (Autore), Irina V. Kulikova (Autore), Vladimir E. Oslovsky (Autore), Olga D. Zakharova (Autore), Alexandra L. Zakharenko (Autore), Sergey N. Mikhailov (Autore), Olga I. Lavrik (Autore)
• Natura: Libro
• Pubblicazione: Taylor & Francis Group, 2018-01-01T00:00:00Z.
• Soggetti: article
• Accesso online: Connect to this object online.

A new class of tyrosyl-DNA phosphodiesterase 1 (TDP1) inhibitors based on disaccharide nucleosides was identified. TDP1 plays an essential role in the resistance of cancer cells to currently used antitumour drugs based on Top1 inhibitors such as topotecan and irinotecan. The most effective inhibitor...